Program Overview
Please read the following information about this continuing pharmaceutical education (CPE) activity before accessing the presentation using the link located at the bottom of this page.
Release Date: July 1, 2009 Expiration Date: March 1, 2011
Accreditation for Pharmacists
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program provides 1 hour (0.1 CEU) of continuing pharmacy education credit (program number 204-000-09-410-H01P).
Methods and Format
This is an online activity consisting of audio, presentation slides, post-test, and an activity evaluation tool. Participants should claim continuing education credit for this internet-based educational activity only if they have not claimed credit for the live webinar. Participants must view the presentation, take the activity post-test, and complete the course evaluation to receive continuing pharmacy education credit. A minimum score of 70% is required on the test in order for credit to be awarded, and participants may print their official statements of continuing pharmacy education credit immediately. The estimated time to complete this activity is 1 hour. This activity is provided free of charge.
Target Audience
This activity is beneficial for pharmacists practicing or with an interest in the areas of cardiology and/or anticoagulant therapy.
Activity Content
Click here to view an overview of the activity content.Learning Objectives
After participating in this knowledge-based educational activity, participants should be able to
- Evaluate the role for statins in preventing venous thromboembolism based upon the results of the JUPITER trial.
- Describe the role for loading doses of atorvastatin prior to percutaneous coronary intervention.
- Describe the safety and efficacy of aspirin plus clopidogrel for stroke prevention in atrial fibrillation.
- List the new ACC/AHA Quality Performance Measures and Test Measures for myocardial infarction and state the role of participation in the National Cardiovascular Data Repository (NCDR) ACTION-Get With the Guidelines registry to improve performance.
- Describe the role of anticoagulant choice, glycoprotein IIb/IIIa inhibitors and 300 mg versus 600 mg clopidogrel loading dose in preventing stent thrombosis for primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
- Compare early versus procedural administration of glycoprotein IIb/IIIa inhibitors in patients with non-ST-segment elevation acute coronary syndrome.
- Estimate the risk of bleeding using a risk prediction tool in patients with acute coronary syndrome or undergoing percutaneous coronary intervention.
Faculty
Sarah A. Spinler, Pharm.D., FCCP, BCPS (AQ Cardiology)
Professor of Clinical Pharmacy
Philadelphia College of Pharmacy
University of the Sciences in Philadelphia
Philadelphia, Pennsylvania
Disclosure Statement
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education's Guidelines for Standards for Commercial Support, ASHP Advantage requires that all individuals involved in the development of program content disclose their relevant financial relationships and that conflicts of interest be identified and resolved prior to delivery of the activity.
The faculty and planners report the following relationships:Sarah A. Spinler, Pharm.D., FCCP, BCPS (AQ Cardiology), declares that she has served as a consultant for The Medicines Company and sanofi-aventis U.S., and as a speaker for Bristol-Myers Squibb, Glaxo SmithKline, sanofi-aventis U.S., and Schering Plough.
Ron DeChant, M.S., R.Ph., declares that he has no relationships pertinent to this activity.
This activity is supported by an educational grant from sanofi-aventis U.S.
Launch Presentation*
Critical Update: Highlights from the American College of Cardiology's 58th Annual Scientific Session (50 minutes)*Allow additional time to complete the post-test and evaluation.
Download Post-Test
Click here to print the post-test for your reference. Please note that to be eligible for continuing pharmacy education credit, you must go to the ASHP Learning Center and complete the test online.
